Home - Inari Medical - Patients First. Always.
Inari Medical is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the products and services you …
FlowTriever® system for the treatment of pulmonary ... - Inari …
Visit our reimbursement page for health economics, reimbursement resources, and support to assist you with the key elements of medical documentation for the coding and billing of …
About Us - Inari Medical - Patients First. Always.
We are a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases. Our employees are dedicated to developing …
Inari Medical Closes Acquisition of LimFlow | Inari Medical, Inc.
Nov 15, 2023 · On November 1, Inari announced a definitive agreement to acquire LimFlow, S.A. for a total upfront consideration of $250 million paid in cash upon closing.
The - Inari Medical
Visit our reimbursement page for health economics, reimbursement resources, and support to assist you with the key elements of medical documentation for the coding and billing of …
The - Inari Medical
Pulmonary Embolism (PE) is a critical cardiac condition caused by blood clots blocking lung arteries. The FlowTriever system is an FDA-cleared therapy designed for the minimally …
Inari Medical Announces First Patient Enrolled in the PEERLESS …
IRVINE, Calif., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) today announced that the first patient has been enrolled in PEERLESS, a prospective, …
Inari Medical to Host Analyst and Investor Meeting Following …
IRVINE, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients …
Rev - Inari Medical
The nitinol element in the RevCore thrombectomy catheter provides seamless interaction with implanted venous stents for the treatment of in-stent thrombosis.
Inari Medical Announces In-hospital and 30-day Outcomes from …
IRVINE, Calif., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the …
- Some results have been removed